Discogenic Pain
0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Vivex BiologicsVIA Disc NP
Vivex BiologicsVIA Disc NP
AbbottNeurostimulation
Clinical Trials (3)
Total enrollment: 599 patients across 3 trials
VIA Disc NP Registry 3.0
Start: Feb 2024Est. completion: Jan 2027500 patients
N/ARecruiting
VIA Disc NP Registry
Start: May 2020Est. completion: Mar 202483 patients
N/ATerminated
Burst Neurostimulation for Discogenic Low Back Pain
Start: May 2019Est. completion: Dec 202116 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 599 patients
2 companies competing in this space